[ASAP] Discovery of a Novel, Highly Potent, and Selective Thieno[3,2- < italic toggle="yes" > d < /italic > ]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.9b01427
Source: Journal of Medicinal Chemistry - Category: Chemistry Authors: Source Type: research
More News: Chemistry